共 49 条
- [45] Long-term adherence to the ACC/AHA class I post-discharge medications and recommendations using multifaceted medical therapy in 2287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE)Trial JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 209A - 209A
- [47] Long-term adherence to the ACC/AHA class I post discharge medications and recommendations using optimal medical therapy in 2,287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 206A - 206A
- [48] Long-term adherence to the ACC/AHA class I post-discharge medications and recommendations using optimal medical therapy in 2,287 patients with established coronary heart disease: Interim data from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial CIRCULATION, 2006, 114 (18) : 798 - 798
- [49] Long-Term Proteasome Inhibition in Multiple Myeloma (MM) Following an in-Class Transition (iCT) from Bortezomib-Based Induction to All-Oral Ixazomib-Lenalidomide-Dexamethasone (IRd) in the United States (US) MM-6 Community-Based Study: Subgroup Analyses of Real-World Data in Patients Aged <75 and ≥75 Years CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S299 - S299